Allerdryl , Banophen, Belix, Ben-Allergin, Bena-D, Benadryl, Benadryl Dye-Free, Benahist, Benoject, Benylin, Compoz, Diahist, Dihydrex, Diphen, Diphenacen-50, Fenylhist, Hyrexin, Insomnal, Nordryl, Nytol with DPH, Sleep-Eze 3, Sominex Formula 2, Tusstat, Twilite, Valdrene, Wehdryl
Classifications: antihistamine; h1-receptor antagonist
Pregnancy Category: C


25 mg, 50 mg capsules, tablets; 6.25 mg/5 mL, 12.5 mg/5 mL syrup; 50 mg/mL injection


H1-receptor antagonist and antihistamine with significant anticholinergic activity. High incidence of drowsiness, but GI side effects are minor. Effects in parkinsonism and drug-induced extrapyramidal symptoms are apparently related to its ability to suppress central cholinergic activity and to prolong action of dopamine by inhibiting its reuptake and storage.

Therapeutic Effects

Competes for H1-receptor sites on effector cells, thus blocking histamine release.


Temporary symptomatic relief of various allergic conditions and to treat or prevent motion sickness, vertigo, and reactions to blood or plasma in susceptible patients. Also used in anaphylaxis as adjunct to epinephrine and other standard measures after acute symptoms have been controlled; in treatment of parkinsonism and drug-induced extrapyramidal reactions; as a nonnarcotic cough suppressant; as a sedative-hypnotic; and for treatment of intractable insomnia.


Hypersensitivity to antihistamines of similar structure; lower respiratory tract symptoms (including acute asthma); narrow-angle glaucoma; prostatic hypertrophy, bladder neck obstruction; GI obstruction or stenosis; pregnancy (category C), lactation, premature neonates, and neonates; use as nighttime sleep aid in children <12 y.

Cautious Use

History of asthma; convulsive disorders; increased IOP; hyperthyroidism; hypertension, cardiovascular disease; diabetes mellitus; older adults, infants, and young children.

Route & Dosage

Allergy Symptoms, Antiparkinsonism, Motion Sickness, Nighttime Sedation
Adult: PO 25–50 mg t.i.d. or q.i.d. (max: 300 mg/d) IV/IM 10–50 mg q4–6h (max: 400 mg/d)
Child: PO/IV/IM 2–6 y, 6.25 mg q4–6h (max: 300 mg/24 h); 6–12 y, 12.5–25 mg q4–6h (max: 300 mg/24 h)

Nonproductive Cough
Adult: PO 25 mg q4–6h (max: 100 mg/d)
Child: PO 2–6 y, 6.25 mg q4–6h (max: 25 mg/24 h); 6–12 y, 12.5 mg q4–6h (max: 50 mg/24 h)



PREPARE: Direct: Give undiluted.  

ADMINISTER: Direct: Give at a rate of 25 mg or a fraction thereof over 1 min.  


Adverse Effects (1%)

CNS: Drowsiness, dizziness, headache, fatigue, disturbed coordination, tingling, heaviness and weakness of hands, tremors, euphoria, nervousness, restlessness, insomnia; confusion; (especially in children): excitement, fever. CV: Palpitation, tachycardia, mild hypotension or hypertension, cardiovascular collapse. Special Senses: Tinnitus, vertigo, dry nose, throat, nasal stuffiness; blurred vision, diplopia, photosensitivity, dry eyes. GI: Dry mouth, nausea, epigastric distress, anorexia, vomiting, constipation, or diarrhea. Urogenital: Urinary frequency or retention, dysuria. Body as a Whole: Hypersensitivity (skin rash, urticaria, photosensitivity, anaphylactic shock). Respiratory: Thickened bronchial secretions, wheezing, sensation of chest tightness.

Diagnostic Test Interference

In common with other antihistamines, diphenhydramine should be discontinued 4 d prior to skin testing procedures for allergy because it may obscure otherwise positive reactions.


Drug: Alcohol and other cns depressants, mao inhibitors compound CNS depression.


Absorption: Readily absorbed from GI tract but only 40–60% reaches systemic circulation. Onset: 15–30 min. Peak: 1–4 h. Duration: 4–7 h. Distribution: Crosses placenta; distributed into breast milk. Metabolism: Metabolized in liver; some degradation in lung and kidney. Elimination: Mostly excreted in urine within 24 h.

Nursing Implications

Assessment & Drug Effects

Patient & Family Education

Common adverse effects in italic, life-threatening effects underlined; generic names in bold; classifications in SMALL CAPS; Canadian drug name; Prototype drug